| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 53 | 2018 | 407 | 7.700 |
Why?
|
| Receptors, Immunologic | 29 | 2017 | 1423 | 3.840 |
Why?
|
| Pneumonia, Pneumococcal | 8 | 2019 | 127 | 2.390 |
Why?
|
| Orthomyxoviridae Infections | 7 | 2018 | 248 | 2.180 |
Why?
|
| Lung | 92 | 2021 | 9857 | 2.050 |
Why?
|
| Phagocytosis | 37 | 2017 | 1539 | 2.040 |
Why?
|
| Scavenger Receptors, Class A | 9 | 2017 | 54 | 1.980 |
Why?
|
| Receptors, Scavenger | 16 | 2017 | 121 | 1.830 |
Why?
|
| Air Pollutants | 25 | 2017 | 2816 | 1.750 |
Why?
|
| Gelsolin | 3 | 2019 | 190 | 1.720 |
Why?
|
| Asthma | 31 | 2017 | 6010 | 1.500 |
Why?
|
| Francisella tularensis | 5 | 2020 | 56 | 1.430 |
Why?
|
| Macrophages | 34 | 2020 | 5660 | 1.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 30 | 2016 | 4424 | 1.080 |
Why?
|
| Influenza, Human | 4 | 2018 | 1479 | 1.070 |
Why?
|
| Bronchoalveolar Lavage Fluid | 38 | 2017 | 768 | 0.910 |
Why?
|
| Endotoxins | 6 | 2017 | 527 | 0.880 |
Why?
|
| Mice, Inbred BALB C | 36 | 2017 | 6386 | 0.870 |
Why?
|
| Animals | 243 | 2022 | 168768 | 0.860 |
Why?
|
| Titanium | 14 | 2014 | 494 | 0.850 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2015 | 689 | 0.850 |
Why?
|
| Mice | 130 | 2022 | 81201 | 0.830 |
Why?
|
| Cytokines | 30 | 2022 | 7323 | 0.820 |
Why?
|
| Neutrophils | 49 | 2018 | 3721 | 0.810 |
Why?
|
| Host-Pathogen Interactions | 3 | 2020 | 1480 | 0.800 |
Why?
|
| Respiratory Hypersensitivity | 9 | 2007 | 274 | 0.790 |
Why?
|
| Nitric Oxide Synthase | 24 | 2009 | 915 | 0.790 |
Why?
|
| Flow Cytometry | 30 | 2016 | 5974 | 0.780 |
Why?
|
| Bronchial Hyperreactivity | 11 | 2014 | 319 | 0.780 |
Why?
|
| Maternal Exposure | 8 | 2017 | 961 | 0.770 |
Why?
|
| Endotoxemia | 3 | 2022 | 207 | 0.760 |
Why?
|
| Nitric Oxide | 18 | 2014 | 2132 | 0.750 |
Why?
|
| Particulate Matter | 14 | 2014 | 2529 | 0.750 |
Why?
|
| Immunologic Factors | 3 | 2019 | 1580 | 0.740 |
Why?
|
| Minor Histocompatibility Antigens | 4 | 2020 | 298 | 0.740 |
Why?
|
| Pneumonia | 15 | 2018 | 2133 | 0.720 |
Why?
|
| Allergens | 10 | 2013 | 1320 | 0.690 |
Why?
|
| Immunity, Innate | 14 | 2016 | 2962 | 0.670 |
Why?
|
| Sexual Maturation | 2 | 2017 | 265 | 0.670 |
Why?
|
| Monokines | 8 | 2000 | 79 | 0.660 |
Why?
|
| Golgi Apparatus | 1 | 2020 | 410 | 0.650 |
Why?
|
| Microspheres | 2 | 2014 | 777 | 0.650 |
Why?
|
| Ozone | 4 | 2013 | 469 | 0.640 |
Why?
|
| Receptors, Lipoprotein | 4 | 2001 | 81 | 0.640 |
Why?
|
| Lipopolysaccharides | 22 | 2022 | 2216 | 0.640 |
Why?
|
| Monocytes | 7 | 2020 | 2596 | 0.640 |
Why?
|
| Interferon-gamma | 14 | 2017 | 3207 | 0.620 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2017 | 459 | 0.620 |
Why?
|
| Disease Susceptibility | 12 | 2018 | 1782 | 0.610 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2009 | 456 | 0.610 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 2011 | 708 | 0.610 |
Why?
|
| Autophagy | 4 | 2020 | 1297 | 0.600 |
Why?
|
| Oxidants | 6 | 2007 | 164 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 42 | 2021 | 21833 | 0.590 |
Why?
|
| Inhalation Exposure | 7 | 2014 | 443 | 0.580 |
Why?
|
| Molecular Mimicry | 1 | 2017 | 201 | 0.580 |
Why?
|
| Streptococcus pneumoniae | 6 | 2016 | 714 | 0.570 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2020 | 581 | 0.560 |
Why?
|
| Acute Lung Injury | 4 | 2018 | 380 | 0.540 |
Why?
|
| Macrophages, Peritoneal | 4 | 2011 | 251 | 0.540 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2000 | 433 | 0.530 |
Why?
|
| Orthomyxoviridae | 1 | 2017 | 156 | 0.530 |
Why?
|
| Pneumonia, Bacterial | 2 | 2017 | 316 | 0.520 |
Why?
|
| Gene Expression Profiling | 12 | 2021 | 9445 | 0.510 |
Why?
|
| Pulmonary Alveoli | 14 | 2014 | 675 | 0.500 |
Why?
|
| Disease Models, Animal | 34 | 2021 | 18034 | 0.500 |
Why?
|
| Carbon | 8 | 2014 | 687 | 0.480 |
Why?
|
| Interleukin-8 | 5 | 2008 | 690 | 0.470 |
Why?
|
| Cricetinae | 18 | 2011 | 2475 | 0.470 |
Why?
|
| Dendritic Cells | 6 | 2017 | 2725 | 0.470 |
Why?
|
| Animals, Newborn | 12 | 2017 | 2726 | 0.460 |
Why?
|
| Particle Size | 14 | 2014 | 1642 | 0.460 |
Why?
|
| Bronchitis | 5 | 2012 | 200 | 0.460 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2018 | 1375 | 0.440 |
Why?
|
| Amino Acid Oxidoreductases | 9 | 1995 | 151 | 0.410 |
Why?
|
| Publications | 1 | 2014 | 195 | 0.400 |
Why?
|
| Mice, Knockout | 33 | 2016 | 14561 | 0.390 |
Why?
|
| Staphylococcus aureus | 5 | 2022 | 1453 | 0.380 |
Why?
|
| Interleukin-13 | 3 | 2017 | 389 | 0.380 |
Why?
|
| Rats | 67 | 2011 | 24252 | 0.380 |
Why?
|
| Cells, Cultured | 32 | 2021 | 19233 | 0.380 |
Why?
|
| Hydrogen Peroxide | 8 | 2011 | 730 | 0.370 |
Why?
|
| Ovalbumin | 12 | 2017 | 719 | 0.370 |
Why?
|
| Antigens, Differentiation | 3 | 2007 | 927 | 0.370 |
Why?
|
| Cell Line | 19 | 2020 | 16000 | 0.370 |
Why?
|
| Communicable Diseases | 1 | 2018 | 880 | 0.360 |
Why?
|
| Opsonin Proteins | 5 | 1996 | 150 | 0.360 |
Why?
|
| DNA Methylation | 7 | 2017 | 4285 | 0.360 |
Why?
|
| Drug Discovery | 1 | 2018 | 1058 | 0.360 |
Why?
|
| Sepsis | 3 | 2022 | 2593 | 0.350 |
Why?
|
| Immunity, Maternally-Acquired | 2 | 2007 | 118 | 0.350 |
Why?
|
| Oxidative Stress | 9 | 2014 | 3084 | 0.350 |
Why?
|
| Reactive Oxygen Species | 8 | 2015 | 2076 | 0.350 |
Why?
|
| Actins | 1 | 2017 | 2121 | 0.340 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2007 | 1320 | 0.340 |
Why?
|
| Estrogens | 3 | 2014 | 1566 | 0.340 |
Why?
|
| Ecotoxicology | 1 | 2008 | 7 | 0.340 |
Why?
|
| Interleukin-4 | 4 | 2009 | 1147 | 0.330 |
Why?
|
| Macrophage Activation | 8 | 2016 | 560 | 0.330 |
Why?
|
| Fluoresceins | 6 | 1999 | 235 | 0.330 |
Why?
|
| RNA, Messenger | 20 | 2017 | 13035 | 0.330 |
Why?
|
| Candida albicans | 1 | 2011 | 394 | 0.320 |
Why?
|
| Chemokine CXCL2 | 10 | 2002 | 115 | 0.320 |
Why?
|
| Interleukin-10 | 5 | 2022 | 1200 | 0.320 |
Why?
|
| Interleukin-12 | 3 | 2006 | 580 | 0.320 |
Why?
|
| Inflammation | 21 | 2022 | 10637 | 0.310 |
Why?
|
| Pneumonia, Aspiration | 10 | 2001 | 145 | 0.310 |
Why?
|
| Immunity | 2 | 2012 | 1014 | 0.310 |
Why?
|
| Eosinophilic Granuloma | 2 | 2017 | 27 | 0.300 |
Why?
|
| Mothers | 4 | 2010 | 2165 | 0.300 |
Why?
|
| Reperfusion Injury | 16 | 2003 | 1026 | 0.300 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2017 | 2408 | 0.290 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2007 | 42 | 0.290 |
Why?
|
| Chemokines | 9 | 2015 | 970 | 0.290 |
Why?
|
| Antigens, CD | 9 | 2013 | 4026 | 0.290 |
Why?
|
| Neutrophil Activation | 2 | 2007 | 186 | 0.290 |
Why?
|
| Ischemia | 22 | 2000 | 1907 | 0.290 |
Why?
|
| Glucocorticoids | 3 | 2017 | 2108 | 0.290 |
Why?
|
| Tetradecanoylphorbol Acetate | 6 | 2020 | 821 | 0.290 |
Why?
|
| Smoke | 3 | 2014 | 227 | 0.280 |
Why?
|
| Epithelial Cells | 7 | 2015 | 3690 | 0.280 |
Why?
|
| Mannose-Binding Lectins | 2 | 2009 | 100 | 0.280 |
Why?
|
| Aerosols | 9 | 2014 | 625 | 0.280 |
Why?
|
| Signal Transduction | 14 | 2020 | 23404 | 0.270 |
Why?
|
| MicroRNAs | 3 | 2017 | 3751 | 0.270 |
Why?
|
| Receptors, Cell Surface | 10 | 2014 | 2865 | 0.270 |
Why?
|
| Microbial Viability | 2 | 2019 | 234 | 0.270 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 844 | 0.270 |
Why?
|
| Methacholine Chloride | 9 | 2014 | 233 | 0.260 |
Why?
|
| CpG Islands | 4 | 2017 | 1170 | 0.260 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 310 | 0.260 |
Why?
|
| Vehicle Emissions | 3 | 2017 | 665 | 0.260 |
Why?
|
| Female | 97 | 2021 | 380193 | 0.260 |
Why?
|
| Chemokines, CXC | 4 | 1996 | 422 | 0.260 |
Why?
|
| Membrane Proteins | 8 | 2015 | 7882 | 0.250 |
Why?
|
| Lectins, C-Type | 3 | 2014 | 589 | 0.250 |
Why?
|
| T-Lymphocytes | 10 | 2007 | 10183 | 0.240 |
Why?
|
| Stress, Psychological | 3 | 2014 | 4245 | 0.240 |
Why?
|
| Protein Kinases | 2 | 2008 | 1640 | 0.230 |
Why?
|
| Environmental Exposure | 5 | 2014 | 4232 | 0.230 |
Why?
|
| Hindlimb | 15 | 2001 | 504 | 0.230 |
Why?
|
| Free Radical Scavengers | 6 | 2004 | 216 | 0.230 |
Why?
|
| Male | 110 | 2021 | 350115 | 0.230 |
Why?
|
| Borrelia burgdorferi | 2 | 2017 | 180 | 0.230 |
Why?
|
| Mesocricetus | 8 | 1999 | 252 | 0.230 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 9647 | 0.220 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2021 | 810 | 0.220 |
Why?
|
| Chemotaxis, Leukocyte | 7 | 1996 | 675 | 0.220 |
Why?
|
| Respiratory Sounds | 2 | 2017 | 696 | 0.220 |
Why?
|
| Recombinant Proteins | 14 | 2019 | 6621 | 0.220 |
Why?
|
| Sex Characteristics | 2 | 2017 | 2585 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2725 | 0.220 |
Why?
|
| Humans | 107 | 2022 | 744366 | 0.220 |
Why?
|
| Oils | 1 | 2002 | 63 | 0.210 |
Why?
|
| Respiratory Burst | 8 | 2000 | 114 | 0.210 |
Why?
|
| Pregnancy | 20 | 2017 | 29144 | 0.210 |
Why?
|
| Base Sequence | 13 | 2017 | 12797 | 0.210 |
Why?
|
| Lung Injury | 5 | 2017 | 436 | 0.210 |
Why?
|
| Oxidants, Photochemical | 1 | 2002 | 78 | 0.200 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2017 | 261 | 0.200 |
Why?
|
| Cell Death | 2 | 2020 | 1707 | 0.200 |
Why?
|
| ADAM Proteins | 2 | 2013 | 243 | 0.200 |
Why?
|
| Nanostructures | 2 | 2019 | 551 | 0.200 |
Why?
|
| Morpholines | 3 | 2000 | 571 | 0.200 |
Why?
|
| Granuloma, Respiratory Tract | 1 | 2021 | 8 | 0.200 |
Why?
|
| Air Pollutants, Occupational | 2 | 2014 | 408 | 0.200 |
Why?
|
| Milk, Human | 1 | 2006 | 490 | 0.190 |
Why?
|
| Hypersensitivity | 2 | 2010 | 1102 | 0.190 |
Why?
|
| Metals, Heavy | 1 | 2002 | 139 | 0.190 |
Why?
|
| Dust | 2 | 2001 | 482 | 0.190 |
Why?
|
| Coal | 2 | 1999 | 119 | 0.190 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2011 | 2751 | 0.190 |
Why?
|
| Growth Substances | 4 | 1996 | 784 | 0.190 |
Why?
|
| Quartz | 5 | 1999 | 24 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 26 | 2002 | 8300 | 0.190 |
Why?
|
| Capillary Permeability | 8 | 2016 | 798 | 0.190 |
Why?
|
| Bodily Secretions | 1 | 2020 | 23 | 0.190 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 3646 | 0.190 |
Why?
|
| Cell Survival | 5 | 2020 | 5882 | 0.190 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 714 | 0.190 |
Why?
|
| Bone Marrow Transplantation | 8 | 2005 | 2765 | 0.180 |
Why?
|
| Immunoglobulin E | 10 | 2017 | 1463 | 0.180 |
Why?
|
| Respiratory System | 3 | 2014 | 557 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 1000 | 0.180 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 2861 | 0.180 |
Why?
|
| Herpes Simplex | 4 | 2013 | 470 | 0.180 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2000 | 66 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 6 | 2017 | 5867 | 0.180 |
Why?
|
| Complement Membrane Attack Complex | 5 | 1999 | 112 | 0.180 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 12073 | 0.180 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 123 | 0.170 |
Why?
|
| Pulmonary Surfactants | 2 | 2000 | 162 | 0.170 |
Why?
|
| Pneumonia, Viral | 4 | 2011 | 3242 | 0.170 |
Why?
|
| Antigens, Surface | 5 | 1989 | 1663 | 0.170 |
Why?
|
| Occupational Exposure | 3 | 2014 | 1793 | 0.170 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2020 | 143 | 0.170 |
Why?
|
| Antioxidants | 5 | 2006 | 1659 | 0.170 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 6 | 2011 | 903 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 14 | 2007 | 9274 | 0.170 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 203 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2017 | 2016 | 0.160 |
Why?
|
| Epithelium | 4 | 2015 | 1679 | 0.160 |
Why?
|
| Scavenger Receptors, Class B | 4 | 2001 | 81 | 0.160 |
Why?
|
| Genome, Human | 1 | 2012 | 4420 | 0.160 |
Why?
|
| Fluorescent Dyes | 4 | 1999 | 1917 | 0.160 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1998 | 123 | 0.160 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2018 | 90 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2017 | 4222 | 0.160 |
Why?
|
| Stress, Physiological | 2 | 2021 | 1403 | 0.160 |
Why?
|
| Estradiol | 2 | 2017 | 2020 | 0.160 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2016 | 165 | 0.160 |
Why?
|
| Immunoglobulin M | 8 | 2003 | 1537 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2017 | 17446 | 0.160 |
Why?
|
| Airway Resistance | 4 | 2004 | 404 | 0.160 |
Why?
|
| Muscle, Skeletal | 9 | 2001 | 4925 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 1996 | 1677 | 0.160 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2000 | 171 | 0.160 |
Why?
|
| Peritoneal Lavage | 1 | 2017 | 35 | 0.160 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1998 | 329 | 0.160 |
Why?
|
| Receptor, trkA | 1 | 2018 | 164 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 323 | 0.150 |
Why?
|
| Sulfoxides | 1 | 2017 | 48 | 0.150 |
Why?
|
| Microarray Analysis | 2 | 2018 | 767 | 0.150 |
Why?
|
| Air Pollution | 3 | 2003 | 2286 | 0.150 |
Why?
|
| Cricetulus | 2 | 2011 | 818 | 0.150 |
Why?
|
| Isothiocyanates | 1 | 2017 | 51 | 0.150 |
Why?
|
| Genome-Wide Association Study | 4 | 2016 | 12262 | 0.150 |
Why?
|
| Oxidation-Reduction | 9 | 2007 | 2184 | 0.150 |
Why?
|
| Integrin beta Chains | 1 | 2017 | 121 | 0.150 |
Why?
|
| Bacillus anthracis | 1 | 2017 | 123 | 0.150 |
Why?
|
| Apoptosis | 6 | 2021 | 9724 | 0.150 |
Why?
|
| Receptors, Somatomedin | 1 | 2017 | 57 | 0.150 |
Why?
|
| CHO Cells | 3 | 2011 | 1409 | 0.150 |
Why?
|
| Catechin | 1 | 2017 | 66 | 0.150 |
Why?
|
| Leukotriene B4 | 8 | 1993 | 294 | 0.150 |
Why?
|
| Legionnaires' Disease | 1 | 2016 | 48 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 1 | 2002 | 722 | 0.140 |
Why?
|
| Sulfur Dioxide | 3 | 1999 | 177 | 0.140 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 300 | 0.140 |
Why?
|
| Thromboxane B2 | 20 | 1993 | 152 | 0.140 |
Why?
|
| Complement Pathway, Alternative | 4 | 2001 | 126 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 3921 | 0.140 |
Why?
|
| Muromonab-CD3 | 1 | 2016 | 96 | 0.140 |
Why?
|
| Reoviridae | 1 | 1996 | 161 | 0.140 |
Why?
|
| Benzofurans | 2 | 2016 | 140 | 0.140 |
Why?
|
| Mice, Mutant Strains | 5 | 2007 | 1865 | 0.140 |
Why?
|
| Chemokine CXCL1 | 5 | 2018 | 101 | 0.130 |
Why?
|
| Environmental Pollutants | 3 | 2008 | 1179 | 0.130 |
Why?
|
| Rats, Inbred Strains | 14 | 2006 | 2186 | 0.130 |
Why?
|
| Gene Expression | 7 | 2007 | 7798 | 0.130 |
Why?
|
| Diaphragm | 4 | 1998 | 349 | 0.130 |
Why?
|
| Receptor, TIE-2 | 1 | 2016 | 178 | 0.130 |
Why?
|
| Administration, Inhalation | 5 | 2009 | 1105 | 0.130 |
Why?
|
| Inflammasomes | 1 | 2020 | 495 | 0.130 |
Why?
|
| Biological Assay | 2 | 1998 | 652 | 0.130 |
Why?
|
| Toxemia | 1 | 1994 | 14 | 0.130 |
Why?
|
| Quinolines | 1 | 2020 | 732 | 0.130 |
Why?
|
| Isoproterenol | 4 | 2001 | 399 | 0.130 |
Why?
|
| Research Report | 1 | 2018 | 355 | 0.130 |
Why?
|
| Myocardium | 12 | 2003 | 4772 | 0.130 |
Why?
|
| Fires | 2 | 2013 | 173 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2013 | 3873 | 0.130 |
Why?
|
| Complement Activation | 5 | 2003 | 453 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 315 | 0.120 |
Why?
|
| Metyrapone | 1 | 2014 | 23 | 0.120 |
Why?
|
| Pneumococcal Infections | 2 | 2016 | 497 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2017 | 551 | 0.120 |
Why?
|
| Myocardial Contraction | 5 | 2001 | 1579 | 0.120 |
Why?
|
| Muscle Contraction | 8 | 1998 | 1235 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 153 | 0.120 |
Why?
|
| Poly I | 2 | 2008 | 5 | 0.120 |
Why?
|
| Macrophage-1 Antigen | 4 | 1996 | 290 | 0.120 |
Why?
|
| Lung Diseases | 7 | 2000 | 1887 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 390 | 0.120 |
Why?
|
| Benzodioxoles | 1 | 2014 | 69 | 0.120 |
Why?
|
| Chemotactic Factors | 5 | 1996 | 199 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2018 | 2926 | 0.120 |
Why?
|
| Isoenzymes | 5 | 1999 | 1728 | 0.120 |
Why?
|
| Indans | 1 | 2014 | 96 | 0.120 |
Why?
|
| Molecular Sequence Data | 15 | 2005 | 18111 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2018 | 2715 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 1995 | 171 | 0.120 |
Why?
|
| Thromboxane A2 | 6 | 1992 | 93 | 0.120 |
Why?
|
| Cytochalasin D | 2 | 2008 | 92 | 0.120 |
Why?
|
| Respiratory Mucosa | 2 | 2015 | 427 | 0.120 |
Why?
|
| Polystyrenes | 1 | 2014 | 112 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2014 | 565 | 0.120 |
Why?
|
| Anniversaries and Special Events | 1 | 2014 | 89 | 0.110 |
Why?
|
| Th2 Cells | 4 | 2007 | 1061 | 0.110 |
Why?
|
| Corticosterone | 1 | 2014 | 310 | 0.110 |
Why?
|
| Zymosan | 3 | 2011 | 124 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2016 | 534 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2005 | 10943 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2019 | 710 | 0.110 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2013 | 56 | 0.110 |
Why?
|
| Complement System Proteins | 4 | 1999 | 795 | 0.110 |
Why?
|
| Immune System | 1 | 2018 | 806 | 0.110 |
Why?
|
| Spleen | 4 | 2020 | 2362 | 0.110 |
Why?
|
| Interleukin-1 | 8 | 2003 | 1263 | 0.110 |
Why?
|
| Chelating Agents | 3 | 2006 | 380 | 0.110 |
Why?
|
| Fluorescence | 2 | 2009 | 751 | 0.110 |
Why?
|
| Deferoxamine | 2 | 2006 | 151 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 6 | 2014 | 1602 | 0.110 |
Why?
|
| Oncogenes | 1 | 2018 | 1265 | 0.110 |
Why?
|
| Neutrophil Infiltration | 3 | 2018 | 391 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 4751 | 0.110 |
Why?
|
| Biological Evolution | 1 | 2018 | 1077 | 0.110 |
Why?
|
| Cell Movement | 8 | 2018 | 5218 | 0.110 |
Why?
|
| Restraint, Physical | 1 | 2014 | 193 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 2 | 2015 | 530 | 0.110 |
Why?
|
| Water | 1 | 2019 | 1395 | 0.110 |
Why?
|
| Bronchoalveolar Lavage | 3 | 2004 | 120 | 0.110 |
Why?
|
| Leukocyte Elastase | 1 | 2013 | 113 | 0.110 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2021 | 1832 | 0.110 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 407 | 0.110 |
Why?
|
| Breath Tests | 2 | 2014 | 280 | 0.110 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 638 | 0.100 |
Why?
|
| Prostaglandins E | 3 | 1989 | 172 | 0.100 |
Why?
|
| Water Pollutants, Chemical | 1 | 1996 | 311 | 0.100 |
Why?
|
| Colony-Stimulating Factors | 2 | 1992 | 221 | 0.100 |
Why?
|
| Platelet Factor 4 | 1 | 1992 | 129 | 0.100 |
Why?
|
| Blotting, Western | 8 | 2013 | 5181 | 0.100 |
Why?
|
| Bleomycin | 1 | 2013 | 512 | 0.100 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2016 | 329 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2016 | 810 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1997 | 985 | 0.100 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1995 | 555 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 2 | 2013 | 743 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 972 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 1219 | 0.100 |
Why?
|
| Acetylcysteine | 3 | 1998 | 271 | 0.100 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1888 | 0.100 |
Why?
|
| Membrane Glycoproteins | 5 | 2004 | 3771 | 0.100 |
Why?
|
| Receptors, Complement | 3 | 2001 | 264 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 8 | 1999 | 1799 | 0.100 |
Why?
|
| Blotting, Northern | 6 | 2004 | 1581 | 0.100 |
Why?
|
| Immunohistochemistry | 18 | 2009 | 11366 | 0.100 |
Why?
|
| Protein Binding | 3 | 2017 | 9384 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2019 | 974 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2016 | 3047 | 0.100 |
Why?
|
| Respiratory Function Tests | 5 | 2017 | 1617 | 0.100 |
Why?
|
| Endocytosis | 3 | 2017 | 985 | 0.100 |
Why?
|
| Plethysmography, Whole Body | 2 | 2001 | 24 | 0.100 |
Why?
|
| Receptors, Complement 3d | 2 | 2002 | 118 | 0.100 |
Why?
|
| Coculture Techniques | 4 | 2003 | 1341 | 0.100 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2010 | 32 | 0.100 |
Why?
|
| Industrial Waste | 2 | 2002 | 23 | 0.100 |
Why?
|
| beta Catenin | 1 | 2016 | 1059 | 0.100 |
Why?
|
| Lyme Disease | 2 | 2017 | 621 | 0.100 |
Why?
|
| Endothelial Cells | 3 | 2012 | 3486 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3505 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 315 | 0.090 |
Why?
|
| Intestines | 5 | 2003 | 1924 | 0.090 |
Why?
|
| Mice, Inbred C3H | 4 | 2005 | 964 | 0.090 |
Why?
|
| Oligosaccharides | 3 | 2001 | 414 | 0.090 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2010 | 43 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 834 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 354 | 0.090 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 3130 | 0.090 |
Why?
|
| Administration, Intranasal | 3 | 2016 | 446 | 0.090 |
Why?
|
| Endothelium, Vascular | 11 | 2016 | 4459 | 0.090 |
Why?
|
| Decidua | 1 | 2010 | 86 | 0.090 |
Why?
|
| Adhesins, Bacterial | 1 | 2010 | 119 | 0.090 |
Why?
|
| Endocannabinoids | 2 | 2022 | 116 | 0.090 |
Why?
|
| Air Pollution, Indoor | 2 | 2011 | 857 | 0.090 |
Why?
|
| Goblet Cells | 1 | 2013 | 287 | 0.090 |
Why?
|
| Eosinophils | 4 | 2017 | 955 | 0.090 |
Why?
|
| Risk | 4 | 2013 | 9688 | 0.090 |
Why?
|
| Bronchi | 6 | 2007 | 840 | 0.090 |
Why?
|
| Hyperoxia | 1 | 2012 | 262 | 0.090 |
Why?
|
| Survival Analysis | 4 | 2019 | 10252 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2021 | 2716 | 0.090 |
Why?
|
| Catalase | 4 | 2006 | 221 | 0.090 |
Why?
|
| Thiourea | 3 | 1999 | 63 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2441 | 0.090 |
Why?
|
| Adolescent | 8 | 2018 | 85779 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2012 | 379 | 0.080 |
Why?
|
| Immune Tolerance | 2 | 2013 | 2259 | 0.080 |
Why?
|
| Vasodilator Agents | 3 | 2009 | 976 | 0.080 |
Why?
|
| Rabbits | 15 | 1998 | 4894 | 0.080 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2009 | 45 | 0.080 |
Why?
|
| Cities | 2 | 2011 | 513 | 0.080 |
Why?
|
| Receptors, Leukocyte-Adhesion | 3 | 1995 | 53 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2012 | 0.080 |
Why?
|
| Breast Feeding | 2 | 2008 | 1338 | 0.080 |
Why?
|
| Edema | 5 | 1999 | 789 | 0.080 |
Why?
|
| Child | 7 | 2018 | 77709 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2126 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2009 | 199 | 0.080 |
Why?
|
| Nocodazole | 1 | 2008 | 97 | 0.080 |
Why?
|
| Pyridines | 2 | 2020 | 2825 | 0.080 |
Why?
|
| Astrocytes | 1 | 2016 | 1273 | 0.080 |
Why?
|
| Cyclic GMP | 4 | 1998 | 409 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2014 | 1132 | 0.080 |
Why?
|
| Cadherins | 1 | 2013 | 907 | 0.080 |
Why?
|
| Drug Synergism | 2 | 2016 | 1794 | 0.080 |
Why?
|
| Infant, Newborn | 5 | 2017 | 25628 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2504 | 0.080 |
Why?
|
| Arginine | 6 | 1998 | 944 | 0.080 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2008 | 148 | 0.080 |
Why?
|
| Weight Loss | 1 | 2019 | 2625 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 2917 | 0.080 |
Why?
|
| Vasculitis | 1 | 2012 | 519 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2014 | 1534 | 0.080 |
Why?
|
| Cell Separation | 3 | 2013 | 1751 | 0.080 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 111 | 0.080 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 340 | 0.080 |
Why?
|
| Complement Pathway, Classical | 4 | 2000 | 97 | 0.080 |
Why?
|
| Inhalation | 2 | 2007 | 143 | 0.080 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2001 | 346 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2018 | 41005 | 0.080 |
Why?
|
| Plasminogen Activators | 1 | 1988 | 209 | 0.080 |
Why?
|
| P-Selectin | 3 | 2000 | 601 | 0.080 |
Why?
|
| Influenza A virus | 1 | 2011 | 456 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 3848 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2016 | 9735 | 0.080 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2013 | 451 | 0.070 |
Why?
|
| Hydrochloric Acid | 6 | 2001 | 76 | 0.070 |
Why?
|
| Muscle, Smooth | 4 | 1997 | 934 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2012 | 2751 | 0.070 |
Why?
|
| Trachea | 5 | 1997 | 1076 | 0.070 |
Why?
|
| Thionucleotides | 2 | 1997 | 107 | 0.070 |
Why?
|
| Adiponectin | 1 | 2013 | 1101 | 0.070 |
Why?
|
| Ligands | 4 | 2017 | 3282 | 0.070 |
Why?
|
| Th1 Cells | 3 | 2007 | 1057 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2018 | 6194 | 0.070 |
Why?
|
| Sputum | 1 | 2009 | 476 | 0.070 |
Why?
|
| Petroleum | 2 | 1998 | 76 | 0.070 |
Why?
|
| Escherichia coli | 2 | 2015 | 4217 | 0.070 |
Why?
|
| Age Factors | 3 | 2021 | 18373 | 0.070 |
Why?
|
| Pertussis Toxin | 2 | 2004 | 178 | 0.070 |
Why?
|
| Receptors, IgG | 2 | 2014 | 582 | 0.070 |
Why?
|
| Biological Products | 1 | 1996 | 860 | 0.070 |
Why?
|
| Oxygen | 4 | 2003 | 4189 | 0.070 |
Why?
|
| Spirometry | 3 | 2014 | 865 | 0.070 |
Why?
|
| Epoxy Compounds | 1 | 2007 | 136 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 7721 | 0.070 |
Why?
|
| Nitroarginine | 4 | 1998 | 66 | 0.070 |
Why?
|
| Histocytochemistry | 9 | 1999 | 719 | 0.070 |
Why?
|
| Atrioventricular Node | 2 | 1997 | 182 | 0.070 |
Why?
|
| Scattering, Radiation | 2 | 2000 | 498 | 0.070 |
Why?
|
| Bacteria | 1 | 2017 | 2115 | 0.070 |
Why?
|
| Lipoproteins | 1 | 2011 | 878 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2014 | 2740 | 0.070 |
Why?
|
| Substance P | 3 | 2001 | 335 | 0.070 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2007 | 104 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 2007 | 290 | 0.070 |
Why?
|
| Phenanthridines | 2 | 1999 | 51 | 0.070 |
Why?
|
| Computational Biology | 1 | 2018 | 3519 | 0.070 |
Why?
|
| Research | 1 | 2014 | 1999 | 0.060 |
Why?
|
| Cloning, Molecular | 5 | 1999 | 4320 | 0.060 |
Why?
|
| Phosphates | 3 | 1999 | 785 | 0.060 |
Why?
|
| Endostatins | 1 | 2005 | 174 | 0.060 |
Why?
|
| DNA Damage | 1 | 2015 | 2432 | 0.060 |
Why?
|
| Protein Kinase C | 2 | 2008 | 1227 | 0.060 |
Why?
|
| Complement C3 | 7 | 2001 | 461 | 0.060 |
Why?
|
| Hospitals | 1 | 2019 | 3954 | 0.060 |
Why?
|
| Mast Cells | 3 | 2001 | 1544 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2003 | 425 | 0.060 |
Why?
|
| Infant | 5 | 2021 | 35134 | 0.060 |
Why?
|
| Quantitative Trait Loci | 2 | 2016 | 2019 | 0.060 |
Why?
|
| Transplantation, Homologous | 5 | 2004 | 4777 | 0.060 |
Why?
|
| Metalloendopeptidases | 2 | 1998 | 396 | 0.060 |
Why?
|
| Interleukin-2 | 6 | 1991 | 1904 | 0.060 |
Why?
|
| BCG Vaccine | 1 | 2007 | 369 | 0.060 |
Why?
|
| Calcium | 6 | 1999 | 5755 | 0.060 |
Why?
|
| Adult | 16 | 2018 | 214052 | 0.060 |
Why?
|
| Mice, Inbred CBA | 6 | 2004 | 448 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 4 | 2009 | 1534 | 0.060 |
Why?
|
| Glycoconjugates | 2 | 1995 | 87 | 0.060 |
Why?
|
| L-Selectin | 2 | 1995 | 214 | 0.060 |
Why?
|
| Young Adult | 5 | 2018 | 56429 | 0.060 |
Why?
|
| Pulmonary Edema | 6 | 1992 | 414 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2014 | 9849 | 0.060 |
Why?
|
| Virus Replication | 2 | 2011 | 2535 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-3 | 2 | 2001 | 63 | 0.060 |
Why?
|
| Ferric Compounds | 2 | 1996 | 374 | 0.060 |
Why?
|
| DNA, Complementary | 4 | 2004 | 2050 | 0.060 |
Why?
|
| Antibody Specificity | 2 | 2003 | 1095 | 0.060 |
Why?
|
| Leukocytes | 5 | 2012 | 2045 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 5 | 1998 | 6313 | 0.060 |
Why?
|
| Cough | 2 | 2017 | 555 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2015 | 1905 | 0.060 |
Why?
|
| Clostridium Infections | 1 | 2010 | 548 | 0.060 |
Why?
|
| COS Cells | 2 | 2010 | 1161 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2018 | 8436 | 0.060 |
Why?
|
| Drug Combinations | 3 | 2006 | 1958 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 57776 | 0.060 |
Why?
|
| Oligonucleotide Probes | 2 | 1995 | 427 | 0.060 |
Why?
|
| Epitopes | 2 | 2003 | 2571 | 0.060 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2003 | 107 | 0.060 |
Why?
|
| Incineration | 1 | 2002 | 20 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19905 | 0.060 |
Why?
|
| Nitrites | 2 | 2000 | 160 | 0.060 |
Why?
|
| RNA Interference | 1 | 2012 | 2890 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2004 | 476 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 6 | 2012 | 6171 | 0.050 |
Why?
|
| Pseudomonas Infections | 2 | 2018 | 613 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 1879 | 0.050 |
Why?
|
| Necrosis | 3 | 2021 | 1643 | 0.050 |
Why?
|
| Milk | 1 | 2006 | 450 | 0.050 |
Why?
|
| Myocardial Infarction | 5 | 2014 | 11718 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14723 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11486 | 0.050 |
Why?
|
| Caseins | 1 | 2003 | 104 | 0.050 |
Why?
|
| Plethysmography | 2 | 1999 | 180 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 2988 | 0.050 |
Why?
|
| Prednisone | 2 | 2017 | 1574 | 0.050 |
Why?
|
| Cell Adhesion | 7 | 2001 | 3144 | 0.050 |
Why?
|
| Microtubules | 1 | 2008 | 1089 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2003 | 224 | 0.050 |
Why?
|
| Models, Biological | 2 | 2017 | 9584 | 0.050 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2002 | 246 | 0.050 |
Why?
|
| Smoking | 2 | 2017 | 8987 | 0.050 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2001 | 36 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8385 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2016 | 21748 | 0.050 |
Why?
|
| Amino Acid Sequence | 5 | 1999 | 13814 | 0.050 |
Why?
|
| Receptors, Vitronectin | 1 | 2001 | 52 | 0.050 |
Why?
|
| Receptors, Muscarinic | 3 | 1998 | 156 | 0.050 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2003 | 215 | 0.050 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2001 | 179 | 0.050 |
Why?
|
| Light | 2 | 2000 | 1374 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3778 | 0.050 |
Why?
|
| Mitochondria | 4 | 1999 | 3514 | 0.050 |
Why?
|
| Mice, Inbred Strains | 4 | 2001 | 1828 | 0.050 |
Why?
|
| Intestinal Diseases | 2 | 1999 | 530 | 0.050 |
Why?
|
| Granulocytes | 1 | 2003 | 548 | 0.050 |
Why?
|
| Phalloidine | 2 | 1991 | 21 | 0.050 |
Why?
|
| Doxycycline | 2 | 2018 | 326 | 0.050 |
Why?
|
| Receptors, Complement 3b | 2 | 2000 | 145 | 0.050 |
Why?
|
| Air | 2 | 2019 | 182 | 0.050 |
Why?
|
| Thromboxane-A Synthase | 6 | 1992 | 35 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2001 | 89 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 4554 | 0.050 |
Why?
|
| Pulmonary Circulation | 2 | 1995 | 739 | 0.050 |
Why?
|
| Risk Factors | 5 | 2008 | 72296 | 0.050 |
Why?
|
| Lymphocyte Activation | 4 | 2000 | 5524 | 0.050 |
Why?
|
| Antimycin A | 2 | 1990 | 30 | 0.050 |
Why?
|
| TRPV Cation Channels | 1 | 2022 | 237 | 0.050 |
Why?
|
| Lectins | 3 | 2006 | 513 | 0.050 |
Why?
|
| Interferon Type I | 2 | 2016 | 542 | 0.050 |
Why?
|
| Forced Expiratory Volume | 3 | 2014 | 1745 | 0.050 |
Why?
|
| Leukocyte Count | 10 | 1999 | 1588 | 0.050 |
Why?
|
| Middle Aged | 10 | 2021 | 213390 | 0.050 |
Why?
|
| Receptors, Cannabinoid | 1 | 2020 | 44 | 0.050 |
Why?
|
| Vero Cells | 1 | 2021 | 485 | 0.050 |
Why?
|
| Carbachol | 2 | 1997 | 226 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 1998 | 246 | 0.050 |
Why?
|
| Interleukin-5 | 2 | 2017 | 273 | 0.050 |
Why?
|
| Cardiotonic Agents | 2 | 2001 | 535 | 0.050 |
Why?
|
| Suspensions | 1 | 2000 | 65 | 0.050 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 6 | 1990 | 83 | 0.050 |
Why?
|
| Aging | 2 | 2016 | 8664 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 1178 | 0.050 |
Why?
|
| Cell Count | 3 | 1999 | 1856 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 1999 | 71 | 0.050 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1999 | 50 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 1988 | 1741 | 0.040 |
Why?
|
| Clonal Deletion | 1 | 2000 | 79 | 0.040 |
Why?
|
| Aged | 6 | 2021 | 163288 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 16690 | 0.040 |
Why?
|
| NF-kappa B | 3 | 2012 | 2499 | 0.040 |
Why?
|
| Species Specificity | 2 | 1999 | 2478 | 0.040 |
Why?
|
| Thromboxanes | 3 | 1989 | 50 | 0.040 |
Why?
|
| Sheep | 9 | 1995 | 1437 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3255 | 0.040 |
Why?
|
| Kidney Tubular Necrosis, Acute | 3 | 1988 | 66 | 0.040 |
Why?
|
| Time Factors | 8 | 2004 | 40075 | 0.040 |
Why?
|
| Escherichia coli Infections | 1 | 2003 | 532 | 0.040 |
Why?
|
| Peroxidase | 7 | 1998 | 611 | 0.040 |
Why?
|
| Lung Neoplasms | 5 | 1998 | 13104 | 0.040 |
Why?
|
| Leg | 3 | 1989 | 1116 | 0.040 |
Why?
|
| Cell Membrane | 4 | 2013 | 3749 | 0.040 |
Why?
|
| Metals | 1 | 2003 | 719 | 0.040 |
Why?
|
| Organ Specificity | 3 | 1999 | 2008 | 0.040 |
Why?
|
| Leishmania donovani | 2 | 1996 | 65 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2455 | 0.040 |
Why?
|
| Interleukin-6 | 3 | 1998 | 3203 | 0.040 |
Why?
|
| Peritoneum | 2 | 2002 | 228 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2003 | 679 | 0.040 |
Why?
|
| Mesothelioma | 1 | 1985 | 818 | 0.040 |
Why?
|
| Solubility | 1 | 2000 | 1088 | 0.040 |
Why?
|
| Encephalitis, Viral | 1 | 1999 | 55 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 1999 | 171 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 1837 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 2938 | 0.040 |
Why?
|
| Cholinergic Fibers | 1 | 1998 | 68 | 0.040 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1998 | 91 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1996 | 1801 | 0.040 |
Why?
|
| Chromans | 1 | 1998 | 122 | 0.040 |
Why?
|
| Superoxides | 2 | 1990 | 387 | 0.040 |
Why?
|
| Propidium | 1 | 1998 | 41 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2007 | 1889 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1999 | 829 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3617 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 976 | 0.040 |
Why?
|
| Terminology as Topic | 2 | 2017 | 1547 | 0.040 |
Why?
|
| Pulmonary Atelectasis | 2 | 1992 | 145 | 0.040 |
Why?
|
| Ethanolamines | 1 | 1998 | 158 | 0.040 |
Why?
|
| Sinoatrial Node | 1 | 1998 | 101 | 0.040 |
Why?
|
| Orosomucoid | 1 | 1997 | 45 | 0.040 |
Why?
|
| Epoprostenol | 3 | 1989 | 254 | 0.040 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1997 | 30 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2006 | 2924 | 0.040 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 12961 | 0.040 |
Why?
|
| DNA | 1 | 1992 | 7294 | 0.040 |
Why?
|
| Nuclear Proteins | 3 | 2009 | 5856 | 0.040 |
Why?
|
| Norepinephrine | 2 | 1998 | 909 | 0.040 |
Why?
|
| Cannabinoids | 1 | 2020 | 166 | 0.040 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 1997 | 42 | 0.040 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 62 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2021 | 502 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 1998 | 291 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2002 | 1460 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 1997 | 134 | 0.040 |
Why?
|
| Neprilysin | 2 | 1997 | 439 | 0.040 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 110 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2012 | 6542 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 1998 | 206 | 0.040 |
Why?
|
| Cell Communication | 2 | 2002 | 1621 | 0.040 |
Why?
|
| Nitroso Compounds | 1 | 1997 | 72 | 0.040 |
Why?
|
| Mast-Cell Sarcoma | 1 | 1996 | 47 | 0.040 |
Why?
|
| Receptors, IgE | 1 | 1999 | 389 | 0.040 |
Why?
|
| Bacterial Capsules | 1 | 1998 | 251 | 0.040 |
Why?
|
| Simplexvirus | 2 | 1998 | 803 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2018 | 314 | 0.040 |
Why?
|
| omega-N-Methylarginine | 4 | 1998 | 111 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1996 | 3773 | 0.040 |
Why?
|
| Legionella pneumophila | 1 | 2016 | 46 | 0.040 |
Why?
|
| Reperfusion | 6 | 1997 | 284 | 0.040 |
Why?
|
| Methacrylates | 7 | 1992 | 107 | 0.040 |
Why?
|
| Lymphocytes | 3 | 2015 | 2617 | 0.040 |
Why?
|
| Enzyme Induction | 4 | 1998 | 475 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 1996 | 19 | 0.040 |
Why?
|
| Complement Inactivator Proteins | 3 | 2001 | 79 | 0.040 |
Why?
|
| Proteins | 5 | 1992 | 6100 | 0.040 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1976 | 62 | 0.040 |
Why?
|
| Caveolins | 1 | 1996 | 104 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 923 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 245 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2016 | 68 | 0.030 |
Why?
|
| Serotyping | 1 | 1996 | 338 | 0.030 |
Why?
|
| Dopamine | 2 | 2022 | 1591 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1996 | 344 | 0.030 |
Why?
|
| Surface Properties | 1 | 2019 | 1184 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 1157 | 0.030 |
Why?
|
| Proteolipids | 1 | 1996 | 117 | 0.030 |
Why?
|
| Peritonitis | 1 | 1998 | 365 | 0.030 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1976 | 173 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 1999 | 676 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 1 | 1995 | 126 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 3 | 1998 | 2007 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1999 | 687 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1998 | 623 | 0.030 |
Why?
|
| Reticulocytes | 1 | 1996 | 290 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1998 | 599 | 0.030 |
Why?
|
| Complement C5 | 3 | 1999 | 112 | 0.030 |
Why?
|
| Asbestos, Serpentine | 1 | 2015 | 24 | 0.030 |
Why?
|
| Printing | 1 | 2015 | 46 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 2038 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2009 | 294 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 1997 | 298 | 0.030 |
Why?
|
| Leukopenia | 5 | 1995 | 213 | 0.030 |
Why?
|
| Calcium Channels | 2 | 1996 | 622 | 0.030 |
Why?
|
| Instillation, Drug | 1 | 1995 | 32 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2016 | 1525 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1976 | 277 | 0.030 |
Why?
|
| Sphincter of Oddi | 1 | 1994 | 22 | 0.030 |
Why?
|
| Lymph Nodes | 2 | 2006 | 3476 | 0.030 |
Why?
|
| Glycolysis | 1 | 1999 | 829 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 688 | 0.030 |
Why?
|
| Lymph | 3 | 1991 | 80 | 0.030 |
Why?
|
| Arginase | 1 | 2015 | 79 | 0.030 |
Why?
|
| Stromal Cells | 2 | 1998 | 1355 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2173 | 0.030 |
Why?
|
| Complement Factor I | 1 | 2014 | 14 | 0.030 |
Why?
|
| Superoxide Dismutase | 4 | 1992 | 596 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10259 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1995 | 136 | 0.030 |
Why?
|
| Intestinal Mucosa | 3 | 2003 | 3037 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1994 | 143 | 0.030 |
Why?
|
| Acute Kidney Injury | 4 | 1989 | 1968 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2001 | 851 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1994 | 226 | 0.030 |
Why?
|
| Phenotype | 3 | 2016 | 16367 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 556 | 0.030 |
Why?
|
| Listeria monocytogenes | 2 | 2007 | 250 | 0.030 |
Why?
|
| Codon | 1 | 1996 | 611 | 0.030 |
Why?
|
| Bronchoconstriction | 1 | 1995 | 143 | 0.030 |
Why?
|
| Kidney | 6 | 1993 | 7184 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 2016 | 289 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 1995 | 624 | 0.030 |
Why?
|
| E-Selectin | 2 | 2012 | 579 | 0.030 |
Why?
|
| Luciferases | 1 | 1996 | 733 | 0.030 |
Why?
|
| Complement C4 | 3 | 2001 | 257 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 1 | 1993 | 45 | 0.030 |
Why?
|
| Thymine DNA Glycosylase | 1 | 2013 | 9 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3464 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 1999 | 1880 | 0.030 |
Why?
|
| Radiation Chimera | 3 | 1998 | 223 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1994 | 179 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 63107 | 0.030 |
Why?
|
| Polyenes | 1 | 1993 | 69 | 0.030 |
Why?
|
| Cell Membrane Permeability | 3 | 2001 | 590 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 764 | 0.030 |
Why?
|
| Histamine | 1 | 1995 | 507 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1976 | 659 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 1998 | 5223 | 0.030 |
Why?
|
| Bronchoconstrictor Agents | 2 | 2007 | 77 | 0.030 |
Why?
|
| Serine Endopeptidases | 2 | 2001 | 1073 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2014 | 213 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 1996 | 973 | 0.030 |
Why?
|
| Interferons | 1 | 1996 | 706 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1996 | 881 | 0.030 |
Why?
|
| Adsorption | 1 | 2013 | 201 | 0.030 |
Why?
|
| Heart | 2 | 1998 | 4464 | 0.030 |
Why?
|
| alpha Karyopherins | 1 | 2012 | 41 | 0.030 |
Why?
|
| Tretinoin | 1 | 1995 | 517 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 898 | 0.030 |
Why?
|
| Immunoglobulin G | 3 | 2007 | 4561 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 20824 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1992 | 136 | 0.030 |
Why?
|
| Tuberculosis | 1 | 2005 | 1912 | 0.030 |
Why?
|
| Metaplasia | 1 | 2013 | 313 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 386 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2018 | 711 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1998 | 1470 | 0.030 |
Why?
|
| Graft vs Host Disease | 3 | 2000 | 2958 | 0.030 |
Why?
|
| Ascitic Fluid | 2 | 1998 | 192 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 677 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 352 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1998 | 6366 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1992 | 248 | 0.020 |
Why?
|
| Capillaries | 1 | 1994 | 773 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2618 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2013 | 583 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15535 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 644 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2000 | 1155 | 0.020 |
Why?
|
| Clostridium sordellii | 1 | 2010 | 3 | 0.020 |
Why?
|
| Renal Circulation | 2 | 1989 | 334 | 0.020 |
Why?
|
| Transgenes | 2 | 2005 | 1009 | 0.020 |
Why?
|
| Permeability | 4 | 1996 | 738 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1085 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2012 | 255 | 0.020 |
Why?
|
| Glycoproteins | 2 | 1996 | 2266 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2013 | 925 | 0.020 |
Why?
|
| Selectins | 2 | 2001 | 102 | 0.020 |
Why?
|
| Virion | 1 | 2013 | 433 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 1970 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 531 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 3666 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1990 | 74 | 0.020 |
Why?
|
| Denmark | 1 | 2012 | 738 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2001 | 2148 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 1097 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 1703 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 12952 | 0.020 |
Why?
|
| Sodium | 1 | 1995 | 1622 | 0.020 |
Why?
|
| Cattle | 1 | 1996 | 3922 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2009 | 9145 | 0.020 |
Why?
|
| Graft Rejection | 2 | 2000 | 4397 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1999 | 3759 | 0.020 |
Why?
|
| Haplotypes | 1 | 2016 | 2779 | 0.020 |
Why?
|
| Enzyme Inhibitors | 5 | 1998 | 3799 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2018 | 1401 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 2133 | 0.020 |
Why?
|
| Progesterone | 1 | 2014 | 775 | 0.020 |
Why?
|
| Platelet Count | 5 | 1991 | 780 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 707 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2009 | 99 | 0.020 |
Why?
|
| Benzamides | 1 | 1995 | 1379 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4208 | 0.020 |
Why?
|
| Ibuprofen | 5 | 1989 | 236 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 1074 | 0.020 |
Why?
|
| Esophagus | 1 | 1995 | 1019 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 636 | 0.020 |
Why?
|
| Immunochemistry | 2 | 1985 | 124 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2013 | 732 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2505 | 0.020 |
Why?
|
| Multigene Family | 1 | 1992 | 1102 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1995 | 1868 | 0.020 |
Why?
|
| Heart Ventricles | 5 | 2001 | 3817 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2013 | 799 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 1991 | 400 | 0.020 |
Why?
|
| Liver | 3 | 2017 | 7475 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 571 | 0.020 |
Why?
|
| Logistic Models | 2 | 2014 | 13409 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 981 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 1988 | 356 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2004 | 593 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2018 | 2948 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1996 | 808 | 0.020 |
Why?
|
| RNA | 1 | 1998 | 2749 | 0.020 |
Why?
|
| Transfection | 2 | 1996 | 5895 | 0.020 |
Why?
|
| Dinitrochlorobenzene | 1 | 2007 | 18 | 0.020 |
Why?
|
| DNA Primers | 2 | 2007 | 2891 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1999 | 2073 | 0.020 |
Why?
|
| Toluene 2,4-Diisocyanate | 1 | 2007 | 10 | 0.020 |
Why?
|
| Lung Compliance | 2 | 1998 | 195 | 0.020 |
Why?
|
| Piperazines | 1 | 1998 | 2488 | 0.020 |
Why?
|
| Epigenomics | 1 | 2013 | 903 | 0.020 |
Why?
|
| Irritants | 1 | 2007 | 44 | 0.020 |
Why?
|
| Indomethacin | 1 | 1988 | 332 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3508 | 0.020 |
Why?
|
| Muscles | 1 | 1992 | 1614 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 1956 | 0.020 |
Why?
|
| Binding Sites | 1 | 1996 | 6111 | 0.020 |
Why?
|
| Fathers | 1 | 2010 | 358 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1985 | 6364 | 0.020 |
Why?
|
| Matrix Metalloproteinase 11 | 2 | 1998 | 14 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 645 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2182 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2007 | 374 | 0.020 |
Why?
|
| Diethylcarbamazine | 3 | 1992 | 23 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 1998 | 215 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 1988 | 0.020 |
Why?
|
| Granuloma | 1 | 2009 | 319 | 0.020 |
Why?
|
| Listeriosis | 1 | 2007 | 149 | 0.020 |
Why?
|
| Piperidines | 1 | 1995 | 1602 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1988 | 573 | 0.020 |
Why?
|
| Free Radicals | 3 | 1992 | 237 | 0.020 |
Why?
|
| Capsaicin | 2 | 1999 | 232 | 0.020 |
Why?
|
| Elastin | 1 | 1988 | 308 | 0.020 |
Why?
|
| Staphylococcal Protein A | 1 | 1985 | 40 | 0.020 |
Why?
|
| Fixatives | 1 | 1985 | 94 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 4671 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 2804 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 625 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 2700 | 0.020 |
Why?
|
| Microcirculation | 3 | 1998 | 1287 | 0.020 |
Why?
|
| Animals, Congenic | 1 | 2005 | 27 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2887 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 3587 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1989 | 2646 | 0.020 |
Why?
|
| Seasons | 1 | 2011 | 1493 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2002 | 1420 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 697 | 0.020 |
Why?
|
| Fibroblasts | 2 | 1995 | 4162 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2006 | 193 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1988 | 601 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 2513 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6933 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2000 | 4153 | 0.020 |
Why?
|
| Family Health | 1 | 2010 | 1281 | 0.020 |
Why?
|
| Membranes | 2 | 1995 | 173 | 0.020 |
Why?
|
| Eosinophilia | 2 | 2000 | 541 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2009 | 1101 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1707 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2018 | 2213 | 0.020 |
Why?
|
| Chromosomes | 1 | 2007 | 596 | 0.020 |
Why?
|
| Acute Disease | 1 | 1995 | 7147 | 0.020 |
Why?
|
| Organ Size | 3 | 1999 | 2251 | 0.010 |
Why?
|
| Uteroglobin | 1 | 2004 | 58 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20130 | 0.010 |
Why?
|
| Respiratory Transport | 1 | 2003 | 8 | 0.010 |
Why?
|
| Health Surveys | 1 | 2014 | 4036 | 0.010 |
Why?
|
| Bisbenzimidazole | 1 | 2003 | 13 | 0.010 |
Why?
|
| Hemodynamics | 3 | 1989 | 4196 | 0.010 |
Why?
|
| Tetracycline | 1 | 2004 | 214 | 0.010 |
Why?
|
| Cell Division | 2 | 2004 | 4569 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2003 | 141 | 0.010 |
Why?
|
| Respiratory Insufficiency | 2 | 1989 | 1199 | 0.010 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2003 | 134 | 0.010 |
Why?
|
| Kinetics | 3 | 1998 | 6476 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8319 | 0.010 |
Why?
|
| Lymphokines | 1 | 1986 | 949 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10483 | 0.010 |
Why?
|
| Guinea Pigs | 2 | 1995 | 1386 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1990 | 1257 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10400 | 0.010 |
Why?
|
| Syndrome | 2 | 2000 | 3252 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1985 | 772 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 644 | 0.010 |
Why?
|
| Bronchopulmonary Sequestration | 2 | 1992 | 42 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1985 | 337 | 0.010 |
Why?
|
| Protease Inhibitors | 2 | 1997 | 791 | 0.010 |
Why?
|
| Gold | 1 | 1985 | 484 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2003 | 249 | 0.010 |
Why?
|
| Imidazoles | 3 | 1998 | 1206 | 0.010 |
Why?
|
| Amino Acids | 1 | 1988 | 1737 | 0.010 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2001 | 12 | 0.010 |
Why?
|
| Chymases | 1 | 2001 | 99 | 0.010 |
Why?
|
| Nitroprusside | 2 | 1995 | 275 | 0.010 |
Why?
|
| Glucose | 1 | 2014 | 4398 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2001 | 32 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1995 | 5023 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1985 | 2327 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 2002 | 411 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1996 | 3461 | 0.010 |
Why?
|
| Bacteremia | 2 | 1998 | 963 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 566 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1986 | 506 | 0.010 |
Why?
|
| Bronchodilator Agents | 1 | 2004 | 502 | 0.010 |
Why?
|
| Lysosomes | 1 | 1985 | 893 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12244 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 793 | 0.010 |
Why?
|
| Blood Pressure | 6 | 1994 | 8551 | 0.010 |
Why?
|
| Perfusion | 2 | 1995 | 1360 | 0.010 |
Why?
|
| Complement C3b | 1 | 2000 | 106 | 0.010 |
Why?
|
| Pleural Neoplasms | 1 | 1985 | 607 | 0.010 |
Why?
|
| Respiration | 2 | 1997 | 1653 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2004 | 686 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1993 | 3112 | 0.010 |
Why?
|
| Nasal Lavage Fluid | 1 | 1999 | 16 | 0.010 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2000 | 53 | 0.010 |
Why?
|
| United States | 2 | 2018 | 69872 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1723 | 0.010 |
Why?
|
| Autoantibodies | 2 | 2000 | 2036 | 0.010 |
Why?
|
| Complement C5a | 1 | 1999 | 107 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 1999 | 68 | 0.010 |
Why?
|
| Critical Illness | 1 | 2012 | 2670 | 0.010 |
Why?
|
| Tachykinins | 1 | 1999 | 78 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2018 | 12207 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2000 | 279 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1998 | 102 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 156 | 0.010 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2000 | 194 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1998 | 104 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2000 | 357 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1998 | 173 | 0.010 |
Why?
|
| Biopsy | 2 | 2001 | 6755 | 0.010 |
Why?
|
| Liver Diseases | 3 | 1991 | 1253 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 1999 | 199 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1997 | 26 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2000 | 758 | 0.010 |
Why?
|
| Isoantigens | 1 | 2000 | 567 | 0.010 |
Why?
|
| Receptors, Interleukin-5 | 1 | 1997 | 19 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1998 | 114 | 0.010 |
Why?
|
| alpha-Macroglobulins | 1 | 1998 | 64 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 595 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 317 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1998 | 145 | 0.010 |
Why?
|
| Calmodulin | 1 | 1998 | 209 | 0.010 |
Why?
|
| Aminoquinolines | 1 | 1998 | 109 | 0.010 |
Why?
|
| Hydrazines | 2 | 1989 | 226 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1998 | 331 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1998 | 321 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1999 | 520 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1997 | 112 | 0.010 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 1997 | 23 | 0.010 |
Why?
|
| Neurons | 1 | 1997 | 9340 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1998 | 170 | 0.010 |
Why?
|
| Histocompatibility | 1 | 1998 | 330 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1998 | 197 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2000 | 527 | 0.010 |
Why?
|
| Penicillamine | 1 | 1997 | 59 | 0.010 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1997 | 97 | 0.010 |
Why?
|
| Recurrence | 1 | 2009 | 8340 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 13882 | 0.010 |
Why?
|
| Antigens, CD19 | 1 | 2000 | 380 | 0.010 |
Why?
|
| Ganglia, Sympathetic | 1 | 1997 | 62 | 0.010 |
Why?
|
| Vitronectin | 1 | 1996 | 44 | 0.010 |
Why?
|
| Guanidines | 1 | 1998 | 193 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1998 | 201 | 0.010 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1996 | 58 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 15520 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1999 | 482 | 0.010 |
Why?
|
| Factor X | 1 | 1996 | 64 | 0.010 |
Why?
|
| Molsidomine | 1 | 1996 | 21 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1996 | 184 | 0.010 |
Why?
|
| Pulmonary Artery | 3 | 1991 | 1912 | 0.010 |
Why?
|
| Housing | 1 | 2001 | 664 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 1992 | 2274 | 0.010 |
Why?
|
| Agglutinins | 1 | 1976 | 29 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1997 | 331 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 1996 | 90 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1976 | 77 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1996 | 50 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1998 | 608 | 0.010 |
Why?
|
| Cryoglobulins | 1 | 1976 | 59 | 0.010 |
Why?
|
| Heme Oxygenase-1 | 1 | 1999 | 381 | 0.010 |
Why?
|
| Nitrates | 1 | 1998 | 265 | 0.010 |
Why?
|
| Indazoles | 1 | 1998 | 290 | 0.010 |
Why?
|
| Catalysis | 1 | 1998 | 762 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1976 | 363 | 0.010 |
Why?
|
| Bronchoscopes | 1 | 1996 | 64 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1989 | 546 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1976 | 349 | 0.010 |
Why?
|
| Meningitis, Bacterial | 1 | 1998 | 218 | 0.010 |
Why?
|
| Biological Clocks | 1 | 1998 | 322 | 0.010 |
Why?
|
| Pyrilamine | 1 | 1995 | 12 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2001 | 1189 | 0.010 |
Why?
|
| Receptors, Neurokinin-2 | 1 | 1995 | 24 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 880 | 0.010 |
Why?
|
| Kidney Diseases | 3 | 1991 | 2148 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1996 | 336 | 0.010 |
Why?
|
| Receptors, Histamine | 1 | 1995 | 22 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 1996 | 322 | 0.010 |
Why?
|
| Autoantigens | 1 | 2000 | 892 | 0.010 |
Why?
|
| Premedication | 2 | 1987 | 258 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1892 | 0.010 |
Why?
|
| Vaccination | 1 | 2007 | 3279 | 0.010 |
Why?
|
| Heart Failure | 1 | 1999 | 10895 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1995 | 227 | 0.010 |
Why?
|
| Dipeptides | 1 | 1997 | 409 | 0.010 |
Why?
|
| Calcitriol | 1 | 1996 | 297 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1998 | 1308 | 0.010 |
Why?
|
| Atropine | 1 | 1995 | 244 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1976 | 549 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 163 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 1996 | 263 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1976 | 349 | 0.010 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 1995 | 129 | 0.010 |
Why?
|
| Electrolytes | 1 | 1995 | 282 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2000 | 1608 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2688 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 318 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 3511 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1995 | 683 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1985 | 4851 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 1996 | 290 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 803 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 4328 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1994 | 414 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2000 | 862 | 0.010 |
Why?
|
| Fibrin | 1 | 1996 | 506 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1454 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 297 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1999 | 1402 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1997 | 1032 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1997 | 647 | 0.010 |
Why?
|
| Mucus | 1 | 1995 | 321 | 0.010 |
Why?
|
| Mechlorethamine | 1 | 1993 | 136 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 1993 | 235 | 0.010 |
Why?
|
| Paraproteinemias | 1 | 1976 | 246 | 0.010 |
Why?
|
| Nasopharynx | 1 | 1996 | 379 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 2000 | 820 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2000 | 3001 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 25039 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1996 | 894 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1985 | 2542 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 2255 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 1995 | 437 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1994 | 682 | 0.010 |
Why?
|
| Evans Blue | 1 | 1992 | 45 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 2027 | 0.010 |
Why?
|
| Hormones | 1 | 1997 | 889 | 0.010 |
Why?
|
| Creatinine | 2 | 1989 | 1919 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 1992 | 143 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1996 | 1802 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 2120 | 0.010 |
Why?
|
| Genes | 1 | 1976 | 1893 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2000 | 1788 | 0.010 |
Why?
|
| Granzymes | 1 | 1993 | 271 | 0.010 |
Why?
|
| Mucins | 1 | 1995 | 564 | 0.010 |
Why?
|
| Dogs | 2 | 1987 | 3912 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1993 | 537 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1995 | 705 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 1993 | 301 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1992 | 249 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1993 | 1162 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1995 | 1683 | 0.010 |
Why?
|
| Tourniquets | 1 | 1992 | 110 | 0.010 |
Why?
|
| Edema, Cardiac | 1 | 1991 | 18 | 0.010 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1992 | 193 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 2460 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1991 | 193 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 705 | 0.010 |
Why?
|
| Fatty Alcohols | 1 | 1990 | 23 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1670 | 0.010 |
Why?
|
| Glycols | 1 | 1990 | 59 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1995 | 1159 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1992 | 444 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 12788 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1996 | 1127 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1992 | 915 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 5099 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1990 | 347 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1990 | 318 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1995 | 1767 | 0.010 |
Why?
|
| Receptors, Thromboxane | 1 | 1989 | 31 | 0.010 |
Why?
|
| Receptors, Prostaglandin | 1 | 1989 | 57 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 1993 | 669 | 0.010 |
Why?
|
| Femoral Vein | 1 | 1990 | 159 | 0.010 |
Why?
|
| Rosette Formation | 1 | 1989 | 153 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1758 | 0.010 |
Why?
|
| Renal Veins | 1 | 1989 | 108 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1995 | 3702 | 0.010 |
Why?
|
| Eicosanoids | 1 | 1990 | 279 | 0.010 |
Why?
|
| Action Potentials | 1 | 1996 | 1806 | 0.010 |
Why?
|
| Sulfonamides | 1 | 1998 | 1940 | 0.010 |
Why?
|
| Blood | 1 | 1991 | 598 | 0.000 |
Why?
|
| Disease Progression | 1 | 2005 | 13286 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1985 | 4839 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1999 | 2897 | 0.000 |
Why?
|
| Intubation, Intratracheal | 1 | 1996 | 1364 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1999 | 3107 | 0.000 |
Why?
|
| Histocompatibility Antigens | 1 | 1989 | 471 | 0.000 |
Why?
|
| Allopurinol | 1 | 1989 | 191 | 0.000 |
Why?
|
| Fistula | 1 | 1989 | 220 | 0.000 |
Why?
|
| Renal Artery Obstruction | 1 | 1988 | 248 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 1378 | 0.000 |
Why?
|
| Organ Culture Techniques | 1 | 1989 | 813 | 0.000 |
Why?
|
| Plasma | 1 | 1990 | 575 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 2569 | 0.000 |
Why?
|
| Sirolimus | 1 | 1993 | 1565 | 0.000 |
Why?
|
| Prostaglandins | 1 | 1987 | 405 | 0.000 |
Why?
|
| Carrageenan | 1 | 1985 | 67 | 0.000 |
Why?
|
| Receptors, Fc | 1 | 1989 | 541 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 1681 | 0.000 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1999 | 4479 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1987 | 854 | 0.000 |
Why?
|
| Lung Volume Measurements | 1 | 1986 | 378 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1986 | 383 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1996 | 3707 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15078 | 0.000 |
Why?
|
| Graft Survival | 1 | 1993 | 3737 | 0.000 |
Why?
|
| Lymph Node Excision | 1 | 1989 | 1262 | 0.000 |
Why?
|
| Insulin | 1 | 1995 | 6582 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1995 | 5534 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1990 | 2789 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2000 | 40559 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1985 | 1400 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2000 | 77460 | 0.000 |
Why?
|
| Brain | 1 | 1997 | 26388 | 0.000 |
Why?
|